Background: Surgical treatment is the only option for long-term survival in patients with colorectal liver metastasis (CRLM). Contrast-enhanced CT and MRI are usually used for preoperative liver imaging. The initial surgical strategy for liver resection is based upon these findings. Further optimization of the surgical strategy by contrast-enhanced intraoperative ultrasound (CE-IOUS) might further improve the surgical outcome. Purpose: To evaluate the current impact of CE-IOUS with SonoVue w on the initial surgical strategy for CRLM. Material and Methods: Eighty-six consecutive patients undergoing open liver resection for CRLM were evaluated retrospectively over a 2.5-year period. The patients underwent 97 operations. Preoperative staging was performed with contrast-enhanced CT in all patients and MRI was available in 66 of 86 patients. CE-IOUS was performed in all patients according to a standardized examination technique. Curved array and linear transducers were used. CRLM were identified in venous phase as hypovascular lesions. CE-IOUS findings were compared with preoperative staging. Results: Combined CT/MRI identified preoperatively 328 CRLM (mean 3.4, range 0-14). Seventy-two additional lesions (18%) were identified in 38 patients during the operation. Intraoperatively 41 additional CRLM in 20 patients were identified by inspection, palpation, and CE-IOUS (10%), and another 31 CRLM in 17 patients were identified by CE-IOUS alone (8%). All additional CRLM detected by CE-IOUS were confirmed by histology if resection was performed. CE-IOUS changed planned operation strategy in 29.9% of operations. A larger resection was necessary in 13.4% of the cases, reduced liver resection was found sufficient in 11.3%, and 5.2% were found inoperable. For patients diagnosed preoperatively with solitary lesions CE-IOUS changed operation strategy in 19% and radical tumor resection would have failed in 4.8% without CE-IOUS. Conclusion: CE-IOUS is essential to ensure optimal and complete tumor resection both in patient with solitary CRLM and multiple metastases.
metachronous CRLM rate increased from 4.0% to 4.3% at 1 year, 12.0% to 13.5% at 3 years, and to 14.5% at 5 years (6, 7) .
Liver resection is the only available treatment with an option of long-term survival in patients with metastases from colorectal cancer (8 -14) . Radical resection of the liver metastases is probably the strongest prognostic factor. A recent review on surgical resection of colorectal liver metastases show a substantially better 5-year survival of patients with histological complete tumor resection vs. resection with tumor residuals (32% vs. 7.2%) (15) . At the time of diagnosis of CRLM, approximately 20% of patients have CRLM initially amenable to resection (16) . In general, resectability criteria are complete tumor resection with histological tumor-free margins and a sufficient future liver remnant (14) . The optimal treatment strategy is mainly decided by an accurate assessment of the imaging characteristics of both the liver and the lesions (17) . That includes the number of lesions, their size and location, the number of involved liver segments, and the hepatic vascular inflow and outflow (17) . A detailed mapping of metastatic liver involvement is therefore essential to establish the most adequate and effective treatment and to avoid unnecessary surgery.
A variety of imaging modalities is used for the staging of CRLM. Most commonly contrast-enhanced computed tomography (CT) of the thorax, abdomen, and pelvis is the initial imaging modality followed by contrast-enhanced magnetic resonance imaging (MRI). With sensitivities on a per-lesion basis for CT, MRI, and fluorine 18 fluorodesoxyglucose (FDG) positron emissions tomography (PET) of 74.4%, 80.3%, and 81.4% respectively in untreated patients, there is still room for improvement (18, 19) . Especially for CRLM ,10 mm the sensitivities of 47.3% and 60.2% for CT and MRI are far from ideal (18) . In addition to preoperative imaging, contrast-enhanced intraoperative ultrasound (CE-IOUS) has been shown to yield significant new information. The CE-IOUS may change the operative plan in up to 50% of patients (20, 21) . Both IOUS with and without contrast have been introduced in many centers, and the examination is presently a routine part of open liver surgery at our hospital. The purpose of this study was to evaluate the current impact of CE-IOUS on the surgical approach which led to changes of the initially planned operation strategy.
Material and Methods
This is a single-center, retrospective study of consecutive patients who underwent open liver resection for metastatic colorectal cancer. Between July 2007 and December 2009 a total of 151 patients received 174 liver resections at our institution. Laparoscopic resection was performed in 55 patients who were excluded from the study since no systematic CE-IOUS examination was performed in these patients. Ten patients had malignant liver lesions other than CRLM and were excluded as well. A total of 86 patients (46 men and 40 women) who underwent 97 operations were included in this study (Table 1 ). Of the included 86 patients 55 had received neoadjuvant treatment.
Preoperative imaging
CT scans of the liver were performed as a three-phase examination (standard) and when necessary an additional late phase was performed. Bolus tracking with the region of interest in the thoracic aorta and a threshold of 120 HU was used to determine arterial and venous phase (10 s respectively 65 s post-threshold delay). The late phase was acquired with 5 min post-injection delay. Scanners used were LightSpeed VCT (GE Healthcare, Phoenix, AZ, USA) and Brilliance CT/64 channels (Philips, Eindhoven, The Netherlands). Acquisition thickness and interval were 0.625/0.625 mm and 0.67/0.67 mm, respectively. The contrast medium was Iomeron (Bracco, Milano, Italy); 150-200 mL 350 mgl/mL were injected at a rate of 5 mL/s. Volume data-sets were acquired and axial, sagittal, and coronal reformations with 3-mm slice thickness were created.
The MRI protocol included axial and coronal T1, T2 sequences and a sequence in liver specific phase. Dynamic acquisitions included a precontrast sequence and contrast enhanced sequences in arterial phase, venous phase, and late phase at 20 -30 s (with bolus tracking), 70 s, and 180 s, respectively. For acquisitions with Resovist no late phase was available. Diffusion-weighted sequences were included from August 2009. Examinations were performed on Intera 1.5T Nova (Philips, Eindhoven, The Netherlands). Slice thickness on standard sequences were 5 mm with 1 mm gap. Dynamic sequences were 3D sequences, acquired with 4 mm slice thickness, and reconstructed to 2 mm slice thickness. Contrast media used listed in chronologic order were, Resovist (0.5 mmol/mL, Bayer Schering Pharma AG, Berlin, Germany); 0.9 or 1.4 mL injected manually, Multi-Hance (334 mg/mL, Bracco, Milano, Italy); 2 mL per 10 kg body weight at an injection rate of 2 mL/s and Primovist (0.25 mmol/mL, Bayer Schering Pharma AG, Berlin, Germany); 1 mL per 10 kg body weight at an injection speed of 1 mL/s. The contrast media were changed during the study period because of recommendations and hospital contract with the companies. CT was performed in all patients prior to surgery within 6 weeks. MRI was performed preoperatively in 70 of the 97 operations. The mean time from the latest CT or MRI scan to operation was 27 days (range, 1 -58 days). That was without five patients (5.8%) who waited 90 days after the latest scan (range, 77-121 days).
IOUS examination
CE-IOUS was performed in all patients according to a standardized examination technique by one of four experienced radiologists (22) . Video capturing was used to document the examinations, enabling later review. Acuson Sequoia TM 512 ultrasound system (Siemens Healthcare, Erlangen, Germany) was used in all cases. Transducers were curved array 4C1 transducer and linear 15L8 or 9L4 in case of narrow spaces. Both curved and linear transducers were used for IOUS and CE -IOUS. In case of planned hemihepatectomi the main focus was on the planned liver remnant.
All examinations started with B-mode ultrasound of the liver with overlapping sweeps. Subsequently 2.4 mL SonoVue w (Bracco, Milan, Italy) were injected into the antecubital vein, followed by 10 mL saline (23) . This was repeated if necessary. The in-built cadence contrast pulse sequencing modus (CPS) was used to suppress the fundamental tissue echo and to increase the non-fundamental echo from the microbubbles (24) .
If new lesions were detected in B-mode, CE-IOUS was performed in arterial, venous, and late phases to distinguish between benign and malignant lesions. If no new lesions were detected in B-mode the whole liver was scanned after 90 s, looking for hypovascular areas which were considered as CRLM. After completion all findings were reevaluated immediately by the experienced radiologist based on the captured CE-IOUS video material and preoperative CT and MRI images.
Imaging analysis
Retrospective analyses of the CT, MRI, and CE-IOUS examinations were evaluated independently by two experienced radiologists. From the CT and MRI examinations the combined total number of lesions was registered. Lesions adjoining each other were treated as one lesion. CE-IOUS findings were compared to combined CT and MRI. Also, intraoperative findings of visible and palpable lesions were compared with preoperative and intraoperative findings. Additional anatomic information or larger tumor extends of already known CRLM were also gathered by CE-IOUS.
Operation
Patient management was decided at a multidisciplinary meeting with experience in the treatment of CRLM. All patients underwent a baseline evaluation, including a history, physical examination, and laboratory tests. CT of the chest, liver, and pelvis were performed in all patients. Resectability for cure required complete resection of all liver metastases, regardless of size, number, distribution, or width of resection margin, while preserving at least 30% of the functioning liver parenchyma, as estimated by CT. Small subcapsular lesions or lesions in the lateral or lower segments (segments II, III, IVb, V, and VI) were considered for a laparoscopic approach. Larger lesions, multiple tumors, lesions located close to major vascular structures, or lesions in posterosuperior segments (I, VII, VIII, IVa) were operated on by an open approach.
Major liver resection was defined as hemihepatectomi or larger. When evaluating changes in the operation method by CE-IOUS a larger/smaller resection was deemed necessary in one or more of the following five settings: detection of so far unknown metastasis; no malignancy confirmed by CE-IOUS; missing lesion; larger/less extent of already known metastasis; or adjustment to anatomical means.
Histology
Resected liver specimens were sent to histological examinations. The specimens were formalin fixated, cut into parallel slices of 5 mm and hematoxylin and eosin stained for further examinations. Size and minimal tumor-free margin to resection surface were recorded for each CRLM.
Statistics
All data were retrospectively collected at the Department of Gastroenterological Surgery and the Department of Radiology and Nuclear Medicine of the Oslo University Hospital. Statistical analyses were performed using SPSS (version 18.0.1; SPSS, Inc, Chicago, IL, USA). When appropriate, mean values were given with their standard deviation.
The study was approved by the Data Protection Officer for Research. The study was presented to the regional ethics committee which had no objections.
Results
An overview of the performed operations after changes were made intraoperatively by the surgeon or after CE-IOUS is listed in ( Table 2 ). The majority of patients were treated with a one-stage procedure, including wedge resection, segmentectomy, hemihepatectomi, and radio frequency ablation (RFA) or a combination of these procedures. For seven patients a two-stage procedure was necessary to achieve radical tumor resection. In these cases, usually the left liver lobe was made tumor-free by wedge resection followed by right portal vein embolization. In the stage-two operation a right hemihepatectomi was most commonly performed. Due to recurrence four patients had to undergo one additional liver resection within the control period (one was found inoperable at operation; the remaining three were treated with wedge resection).
Due to the retrospective nature of this study detailed differentiation between IOUS and CE-IOUS was not always possible. Therefore both examinations were considered as one referring to the highest standard -CE-IOUS.
CE-IOUS impact on operation method
Preoperative CT/MRI identified 328 CRLM (mean 3.4, range 0 -14). Seventy-two additional lesions were identified during the operation. Of these, 41 lesions (20 patients) were identified by both inspection, palpation, and CE-IOUS, and 31 lesions (17 patients) were identified by CE-IOUS only. An overview of all CRLM detected by CE-IOUS alone is given in Table 3 . Eight lesions described as CRLM by CT/MRI were either characterized as benign lesions or no lesion by CE-IOUS. The preoperative operation strategy was altered in 46 of the 97 performed operations. Based on inspection and palpation changes were made in 17 cases, and for 29 cases CE-IOUS was decisive ( Fig. 1) .
Palpation and inspection changed the operation in 12 patients due to additional metastasis resulting in a larger resection in eight patients and inoperability in four patients. Anatomical reasons changed the operation in one patient. Four patients were found inoperable (extrahepatic disease and larger tumor extent each in two cases).
Of the 29 (29.9%) cases modified by CE-IOUS 13 (13.4%) were treated with a larger resection and 11 (11.3%) with a smaller resection. Five cases (5.2%) were found inoperable. An example of an additional CRLM is shown in Fig. 2 In case of inoperability the patients were followed up clinically to confirm malignancy. Twenty-one patients were evaluated preoperatively to have solitary lesion and were planned for open liver resection. These patients were in addition to the earlier described results analyzed separately. Initial operation strategy was modified in seven patients. In three patients the operation strategy was modified based on evaluation by the surgeon because of new metastases. In four patients CE-IOUS was decisive. One case had no tumor, one was modified to RFA, one had a smaller resection, and in one patient CE -IOUS revealed one so far unknown metastasis. No patient with a solitary lesion was found inoperable.
. A larger resection was performed because of additional

Discussion
With surgery as currently the only option for long-term survival in patients with CRLM, optimal operation planning is mandatory (25) . Surgical success is dependent on selection of patients, preoperative detection of CRLM and intraoperative localization of all intrahepatic and extrahepatic tumor deposits and their complete extraction. Despite a multimodal preoperative diagnostic approach, imaging of CRLM remains challenging. IOUS has an important role as the last diagnostic modality prior to liver resection. Due to its high resolution, IOUS is associated with the highest sensitivity (94-100%) and specificity (95-100%) concerning the number and localization of the liver lesions and their relation to major vascular and biliary structures (26) (27) (28) (29) . The positive impact on resection margin, decreased operative blood loss, and surgical outcome have been demonstrated previously (30) . However, information about tumor vascularity and tissue microcirculation are not provided (31) . The additive value of CE-IOUS have been shown in recent studies, reporting identification of additional CRLM in 13 -33% of patients (20, 31, 32) . Since the value of CE-IOUS depends on the quality of the preoperative staging we evaluated the current value of routine CE-IOUS in this study.
CE-IOUS alone changed planned operation strategy in 29.9% of operations. A larger resection was necessary in 13.4% of cases, smaller liver resection was found sufficient in 11.3% and 5.2% were found inoperable. Another 17.5% operations were changed based on surgeons examination previous to CE-IOUS with no further strategy modification by CE-IOUS in these cases. Our findings are similar to other studies showing that IOUS yields significant new information in 7 -44% of patients (33) (34) (35) . Leen et al. described an alteration of the surgical plan by CE-IOUS alone in 29.8% compared to combined CT/MRI and IOUS (20) . Our findings confirm that CE-IOUS is an essential tool before liver resection despite improvements in preoperative imaging with CT and MRI.
In 1986 Ekberg et al. stated that indications for liver resection were no more than three CRLM, resection margins !10 mm, and absence of extrahepatic disease (36) . Currently, patients are considered resectable if a complete resection of all intrahepatic and extrahepatic tumor sites is feasible with negative margins and a sufficient future liver remnant can be preserved (14) . Optionally portal vein embolization may precede resection to ensure maximal hypertrophy of the future liver remnant (14) . Furthermore, until recently patients initially considered as unresectable were definitively treated by palliative chemotherapy, with little chance of 5-year survival (12, 37) . With advances in chemotherapy and targeted therapy, patients initially classified as unresectable can be rendered amenable for surgical intervention in 15 -20% (38) . The more aggressive surgical approach might have increased the possibility for the presence of so far undetected CRLM. Compared to the study of Leen et al. where mean number of CRLM was 1.95 + 1.79, it was 4.36 + 3.65 in our study (20) . Furthermore 73.3% of patients included in our study had synchronous CRLM compared to 15.0% in the study of Leen et al. These findings might demonstrate the current challenges for imaging of CRLM in patients with often relatively advanced disease. Changes in imaging characteristics of liver tissue as a result of chemotherapy and changes of liver anatomy after preceding liver resection are leading to higher demands on imaging modalities for the detection of CRLM. Spatz et al. found in a recent study IOUS to be the most sensitive imaging modality in patients treated with neoadjuvant chemotherapy (sensitivity IOUS 94%; PET 63% and CT/MRI 65%) (29) .
Most of distant colorectal metastases occur within the first 3 years after resection of the primary tumor and are confined to the liver in more than 40% (39) . The main reason for tumor recurrences after putative complete tumor removal is the presence of undetected tumor at the time of surgery (40) . Despite radiologic remission Adam et al. found that the probability for complete pathological remission may be as low as 4% (41) . This underlines the importance of IOUS/CE-IOUS, especially in a neoadjuvant setting. However, despite the use of CE-IOUS, the persisting high recurrences rates might indicate a significant number of false-negative CE-IOUS findings for small lesions and subsequently the need of further improvements.
For patients preoperatively diagnosed as having a solitary lesion, CE-IOUS changed operation strategy in 19.0% (4/21 operations). CE-IOUS identified an additional CRLM in one patient. If initially planned operation strategy would not have been modified by CE-IOUS, radical tumor resection would have failed in 4.8% of operations. Yet one has to admit that preoperative imaging was not considered optimal in that specific case because no MRI was available and the CT scan was approximately 2 months old. That might make the impact of CE-IOUS debatable in that specific case. Nevertheless, our findings demonstrate the importance of CE-IOUS also for patients with preoperatively solitary CRLM. However, many of these patients are treated with laparoscopic resection without CE-IOUS or with reduced possibility of systematic CE-IOUS. In our opinion, the availability of systematic CE-IOUS covering the whole liver should always be an important issue, when considering patients for laparoscopic treatment.
Despite the usage of transcutaneous transducers, a satisfying examination of the liver was possible in all cases. The use of dedicated intraoperative transducers might have simplified or improved the examination but those transducers were unfortunately not available at our institution. If the usage of dedicated intraoperative transducer might have resulted in the detection of further CRLM or even more changes of operation strategy could therefore not be investigated in our study. The usage of transcutaneous transducers might be one major drawback of the study, however, it demonstrates that despite the lack of dedicated equipment CE-IOUS has a high value and should be considered in case of liver resection for CRLM.
The time between the last scan and operation was especially long for five patients (mean, 90 days). But since operation strategy was only modified by CE-IOUS in one patient who had received neoadjuvant treatment it was not considered relevant for evaluation of our results (modification was due to relocation of a known CRLM from segment eight to segment four).
The patients included in this study represent a heterogeneous cohort in terms of extent of their metastatic disease and total number of liver resections performed. General interpretation of the data and consequences for diagnosis and treatment may vary. However, the data show not only the importance of CE-IOUS, but also the challenges of modern surgery for CRLM where treatment strategy must be tailored individually for each patient. That implies also that the impact of CE-IOUS on operation strategy might strongly depend on the initial surgical strategy. For instance, the impact might differ significantly if a more traditional approach is applied compared to an ultrasound guided approach (42) . A recent study indicates that IOUS/CE-IOUS might allow radical liver resection in one stage where traditional approaches would have indicated a two-stage approach with 20 -25% chance of inoperability at stage two (43) .
In conclusion, CE-IOUS during operation for CRLM changed planned operation strategy in approximately 30% of the operations. For patients diagnosed with solitary lesion the CE-IOUS changed operation strategy in 19%. CE-IOUS has the potential to identify so far unknown small CRLM of ,10 mm. We conclude that CE-IOUS was essential to ensure optimal and complete tumor resection both in patient with solitary CRLM and multiple metastases.
